๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A radioenzymatic ultramicro method applicable to the measurement of a wide range of metabolites

โœ Scribed by Michael N. Berry; Ronald D. Mazzachi; Ainsley H. Chalmers


Publisher
Elsevier Science
Year
1981
Tongue
English
Weight
633 KB
Volume
118
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.

โœฆ Synopsis


A radioenzymatic method suitable for the estimation of nanomole amounts of a wide range of metabolites is described. The method involves the conversion of [ l-'4C]a-ketoglutarate to [ l-'4C]glutamate by NADH or NADPH generated stoichiometrically in preliminary reactions specific for the metabolite under assay. The labeled glutamate is then decarboxylated with glutamate decarboxylase and the liberated "'CO2 trapped and measured by scintillation counting. Examples of the variety of substrates that can be estimated by this method include procedures for the determination of lactate, glucose, ammonia, pyruvate, malate, sorbitol, and NAD(P)H. However, most enzymatic spectrophotometric or fluorimetric metabolite assays should be readily adaptable for radioenzymatic assay. In validation of the method, glucose and lactate were measured in whole blood or plasma, and the values obtained by the radioenzymatic method were found to correlate well with established clinical procedures. The method lends itself to both clinical and basic biochemical applications, can be used over a very wide range of metabolite concentrations, and is sufficiently sensitive to allow the measurement of an amount of metabolite as low as 0.25 nmol.

MATERIALS AND METHODS

Enzymes and Cofactors

Glutamate decarboxylase (EC 4.1.1.15) (20 U/mg) was either purchased from Worthington Biochemical Corporation, Freehold, New Jersey, or prepared from a crude


๐Ÿ“œ SIMILAR VOLUMES


A General, Wide-Range Spectrofluorometri
โœ D.E. Epps; T.J. Raub; F.J. Kezdy ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 660 KB

Binding of drugs to serum albumin is one of the most important pharmacokinetic determinants and the design of drugs should take advantage of this property. In the present work, the fluorescent ligands Warfarin and dansylsulfonamide were used as probes of IIA site of human albumin and dansylsarcosine